Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 6/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.50 |
| ▸ | ABAT | P80404 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 4/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | IDO1 | P14902 | 2/20 | 0.42 |
| ▸ | HTR1A | P08908 | 1/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | HTR3A | P46098 | 1/20 | 0.42 |
| ▸ | BACE1 | P56817 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3694910 | 0.79 | TSHR (0.43) | CA2ALDH1A1CA12CA1TYR | |
| SCHEMBL16904622 | 0.78 | ESR1 (0.55) | ESR1ESR2ABATCA2KDM4E | |
| SCHEMBL28494268 | 0.75 | ESR1 (0.59) | ESR1ESR2ABATCA2KDM4E | |
| SCHEMBL5249523 | 0.74 | PYCR1 (0.52) | ALDH1A1IDO1TAAR1L3MBTL1NPC1 | |
| SCHEMBL9331371 | 0.74 | TRPA1 (0.52) | ESR1ESR2ABATCA2KDM4E | |
| SCHEMBL1921131 | 0.74 | PYCR1 (0.50) | KDM4EALDH1A1IDO1SLC6A2TAAR1 | |
| SCHEMBL448467 | 0.74 | MMP3 (0.57) | ESR1ESR2ABATCA2KDM4E | |
| SCHEMBL910567 | 0.74 | ESR1 (0.57) | ESR1ESR2ABATCA2KDM4E | |
| SCHEMBL11193453 | 0.74 | PYCR1 (0.30) | — | |
| SCHEMBL18770738 | 0.74 | PYCR1 (0.54) | IDO1TAAR1MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-214344565-U | Novel device for extracting Sela alkynol effective components from selaginella tamariscina | 昆明远方生物制品有限公司 | 2021-10-08 | — | — | CN | claimed |
| CN-113429944-A | Novel ionic liquid-based organic heat carrier material and preparation method thereof | 绍兴七轩新材料科技有限公司 | 2021-09-24 | — | — | CN | claimed |
| CN-108101755-B | Method for preparing chiral 4- (2-propargyl) phenol compound | 中国科学院大连化学物理研究所 | 2021-03-02 | — | — | CN | claimed |
| CN-108101755-A | A kind of method for preparing chiral 4- (2- propargyls) phenol compound | 中国科学院大连化学物理研究所 | 2018-06-01 | — | — | CN | claimed |
| EP-0922050-B1 | 3-DESCLADINOSE-2,3-ANHYDROERYTHROMYCIN DERIVATIVES | ABBOTT LAB (US) | 2003-07-30 | — | — | EP | claimed |
| US-12545756-B2 | Curable resin composition, molded article and method for producing same | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-02-10 | — | — | US | disclosed |
| US-12398230-B2 | Curing resin composition, curing method therefor, and molded article | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-08-26 | — | — | US | disclosed |
| CN-115698110-B | Resin composition for curing, molded article, and method for producing same | 三菱瓦斯化学株式会社 | 2025-04-29 | — | — | CN | disclosed |
| CN-114057469-B | Ceramic matrix composite stealth coating and preparation method thereof | 砺剑防务技术集团有限公司 | 2024-07-19 | — | — | CN | disclosed |
| CN-114466877-B | Resin composition for curing, method for curing the same, and molded article | 三菱瓦斯化学株式会社 | 2024-05-14 | — | — | CN | disclosed |
| US-11901249-B2 | Curable composition and cured product thereof | DIC CORPORATION (JP) | 2024-02-13 | — | — | US | disclosed |
| CN-112119104-B | Epoxy (meth) acrylate resin composition, curable resin composition, cured product, and article | DIC株式会社 | 2023-09-29 | — | — | CN | disclosed |
| EP-1203760-A1 | Method for producing cyclopropanecarboxylates | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-05-08 | — | — | EP | disclosed |
| US-20020052525-A1 | Method for producing cyclopropanecarboxylates | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-05-02 | — | — | US | disclosed |
| CN-1282729-A | Preparation method of cyclopropane carboxylic acid ester | SUMITOMO CHEMICAL CO (JP) | 2001-02-07 | — | — | CN | disclosed |
| EP-1061065-A2 | Methods for producing cyclopropane carboxylates | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-12-20 | — | — | EP | disclosed |
| CN-1255489-A | Method for preparing cyclopropane carboxylic ester | SUMITOMO CHEM ENG (JP) | 2000-06-07 | — | — | CN | disclosed |
| EP-0992479-A1 | Method for producing cyclopropanecarboxylates | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-04-12 | — | — | EP | disclosed |
| US-4873284-A | Heat-curable molding compositions | BASF AKTIENGESELLSCHAFT (DE) | 1989-10-10 | — | — | US | disclosed |
| EP-0276737-A2 | Thermocurable moulding compounds | BASF Aktiengesellschaft (DE) | 1988-08-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020052525-A1 | Method for producing cyclopropanecarboxylates | CYP8B1, SRD5A2, CYP21A2 | ESR1 4123/4885ESR2 2360/4885ABAT 2581/4885 |
| US-12545756-B2 | Curable resin composition, molded article and method for producing same | ASH2L, UFL1, CARM1 | ESR1 2358/4885ESR2 2561/4885ABAT 3515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.